Antonio Heras-Garvin Selected Research

Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)

11/2021

ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Heras-Garvin Research Topics

Disease

9	Multiple System Atrophy 11/2021 - 03/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 01/2020
4	Synucleinopathies 11/2021 - 01/2020
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2020
2	Dementia (Dementias) 01/2021 - 01/2020
1	Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy) 11/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Multiple Sclerosis 01/2020
1	Gliosis 01/2020
1	Proteostasis Deficiencies 01/2019

Drug/Important Bio-Agent (IBA)

7	SynucleinsIBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	3- (1,3- benzodioxol- 5- yl)- 5- (3- bromophenyl)- 1H- pyrazoleIBA 01/2020 - 01/2019
1	ATH434IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SaltsIBA 01/2020
1	CytokinesIBA 01/2020
1	ChemokinesIBA 01/2020
1	PrionsIBA 03/2016

Therapy/Procedure

1	Therapeutics 01/2020